In this study, the expression of TIM3 and its correlation with CD8+TILs exhaustion, the key ligand of TIM3, and the potential pathway of TIM3-mediated CD8+TILs in DLBCL were analyzed. The gene discussed is HAVCR2; the disease is diffuse large B-cell lymphoma.